SUBSCRIBE
SUBSCRIBE

Synexa Life Sciences

Synexa Life Sciences is a biomarker and bioanalytical lab CRO, specialising in the development, validation and delivery of a wide range of complex and custom-designed assays.

With a team of over 200 staff across three global laboratory locations; Manchester, Turku (Finland) and Cape Town, we provide innovative solutions to support our customers to achieve their clinical milestones.

Our main areas of expertise include biomarker identification and development, large and small molecule clinical bioanalysis, (soluble) biomarker analysis (utilising MSD, LC-MS/MS, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry, ELISpot and Fluorospot) and genomic services to support clinical trials and translational studies.

We pride ourselves on our deep scientific expertise and ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis.

NEWS
GSK's headquarters office building in Poznan, Poland
Manufacturing
GSK Commits $30B To Boost US R&D, Manufacturing Operations
The multi-billion, multi-year investment comes as many of GSK’s pharma peers pull away from the U.K., either suspending or completely canceling previous commitments.
September 17, 2025
 · 
1 min read
 · 
Tristan Manalac
Podcast
China Crackdown, UK Exit, Novo Layoffs, Adcomm Flip Flop, More
The White House is clamping down on pharma’s ability to buy new molecules from Chinese biotechs; Sanofi, Merck and others abandon the U.K. after the introduction of a sizeable levy; Novo CEO Maziar Mike Doustdar lays off 9,000 while the company presents new data at EASD; Capsida loses a patient in a gene therapy trial; and CDER Director George Tidmarsh walks back comments on FDA adcomms.
September 17, 2025
 · 
2 min read
 · 
Heather McKenzie
An architect designs a building on a laptop. Art collage.
Manufacturing
Lilly to Bring Nearly 2,500 Jobs to Virginia With $5B Manufacturing Plant
This manufacturing site in Richmond, Virginia, is the first of four projects that Eli Lilly plans to reveal this year as part of a $27 billion U.S. investment announced earlier this year.
September 17, 2025
 · 
1 min read
 · 
Tristan Manalac
Indianapolis, U.S. - April 16, 2016: Eli Lilly and Company World Headquarters. Lilly makes Medicines and Pharmaceuticals VII
Obesity
Lilly Paints ‘Competitive Profile’ for Obesity Pill With Detailed Late-Stage Data
The over-representation of males and Hispanic patients in Eli Lilly’s Phase III ATTAIN-1 study could explain why orforglipron “underperformed” expectations in a previous readout, according to analysts at BMO Capital Markets.
September 17, 2025
 · 
2 min read
 · 
Tristan Manalac
Futuristic robot eye Artificial intelligence abstract future of technology vector design concept. AI technology hologram eye scanning analysis big data, cyber security, radar tracker, survey, graph.
Startups
Ollin Emerges From Stealth With $100M To Develop Eye Disease Bispecifics
OLN324 targets both VEGF and Ang2, the same mechanism of action as Roche’s Vabysmo, the Swiss giant’s multi-blockbuster treatment for wet macular degeneration and diabetic macular edema.
September 17, 2025
 · 
2 min read
 · 
Tristan Manalac
Illustration showing business discussion, questioning
Career Advice
Stop Selling the Dream, Start Telling the Truth
Transparency doesn’t drive people away. It attracts the right ones and keeps them committed. Leadership coach Angela Justice discusses the problem with leaders only selling the upside and the value of setting accurate expectations from the start.
September 17, 2025
 · 
3 min read
 · 
Angela Justice
concept of bioengineering or healthcare technology, graphic of 3D pill combined with electronic pattern
Artificial Intelligence
The Future of Pharma Is Predictive Care Powered by Consumers, AI: PwC
The world of healthcare is evolving to more predictive care and patients are taking greater control—a trend already emerging around GLP-1 weight loss treatments. As PwC warns, pharma will need to be ready.
September 17, 2025
 · 
2 min read
 · 
Annalee Armstrong
Akeso CEO Michelle Xia, who worked in the lab during the biotech's initial stages after founding.
China
Choosing China: Akeso’s $3M Beginnings and the Rise of China’s Biotech Sector
From a small team of researchers and skipped salaries, CEO Michelle Xia has steered Akeso to become one of the most exciting companies in the industry today.
September 17, 2025
 · 
8 min read
 · 
Tristan Manalac
TV HEad
FDA
In New DTC Ad Crackdown, FDA Trying To Close a Loophole That Isn’t
While the FDA is trumpeting this new initiative as “sweeping reforms” to the way drug companies can advertise, experts say the regulator is going after a problem that doesn’t exist.
September 17, 2025
 · 
7 min read
 · 
Annalee Armstrong
Load More
Visit website
Email Us
IN THE PRESS
Press Releases
Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer
June 2, 2025
 · 
4 min read
BioMidwest
Inotiv, Inc. Announces New Site Openings and Expansions Supporting Additional Capacity and Service Offerings
December 8, 2022
 · 
4 min read
Business
Parexel Announces Strategic Collaboration with Synexa Life Sciences and Drawbridge Health for COVID-19 Clinical Serology Testing Solution
November 2, 2020
 · 
4 min read
JOBS